STRAP
gene geneOn this page
Also known as UNRIPpt-wdMAWD
Summary
STRAP (serine/threonine kinase receptor associated protein, HGNC:30796) is a protein-coding gene on chromosome 12p12.3, encoding Serine-threonine kinase receptor-associated protein (Q9Y3F4). The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs.
Enables RNA binding activity. Involved in maintenance of gastrointestinal epithelium and spliceosomal snRNP assembly. Acts upstream of with a positive effect on negative regulation of transforming growth factor beta receptor signaling pathway. Located in cytosol. Part of SMN complex. Implicated in adenocarcinoma; colorectal carcinoma; large cell carcinoma; lung carcinoma; and squamous cell neoplasm.
Source: NCBI Gene 11171 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 45 total
- Druggable target: yes
- MANE Select transcript:
NM_007178
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30796 |
| Approved symbol | STRAP |
| Name | serine/threonine kinase receptor associated protein |
| Location | 12p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | UNRIP, pt-wd, MAWD |
| Ensembl gene | ENSG00000023734 |
| Ensembl biotype | protein_coding |
| OMIM | 605986 |
| Entrez | 11171 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000025399, ENST00000419869, ENST00000536737, ENST00000538718, ENST00000539887, ENST00000541731, ENST00000888770, ENST00000888771, ENST00000927387, ENST00000927388, ENST00000927389, ENST00000927390, ENST00000927391, ENST00000956572
RefSeq mRNA: 1 — MANE Select: NM_007178
NM_007178
CCDS: CCDS8676
Canonical transcript exons
ENST00000419869 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000724091 | 15883541 | 15883676 |
| ENSE00002297307 | 15882387 | 15882819 |
| ENSE00003479597 | 15897882 | 15898018 |
| ENSE00003494228 | 15894047 | 15894143 |
| ENSE00003537668 | 15902917 | 15903478 |
| ENSE00003596444 | 15900947 | 15901012 |
| ENSE00003596910 | 15889928 | 15890009 |
| ENSE00003602559 | 15899904 | 15900053 |
| ENSE00003604550 | 15890597 | 15890669 |
| ENSE00003694195 | 15895359 | 15895496 |
Expression profiles
Bgee: expression breadth ubiquitous, 305 present calls, max score 99.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 172.2765 / max 1290.3241, expressed in 1828 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 124503 | 167.9111 | 1828 |
| 124504 | 4.3072 | 1495 |
| 124502 | 0.0582 | 17 |
Top tissues by expression
305 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 99.52 | gold quality |
| oocyte | CL:0000023 | 99.36 | gold quality |
| corpus epididymis | UBERON:0004359 | 98.99 | gold quality |
| pons | UBERON:0000988 | 98.81 | gold quality |
| cauda epididymis | UBERON:0004360 | 98.81 | gold quality |
| type B pancreatic cell | CL:0000169 | 98.72 | gold quality |
| caput epididymis | UBERON:0004358 | 98.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.67 | gold quality |
| embryo | UBERON:0000922 | 98.64 | gold quality |
| ventricular zone | UBERON:0003053 | 98.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 98.57 | gold quality |
| cortical plate | UBERON:0005343 | 98.55 | gold quality |
| adult organism | UBERON:0007023 | 98.51 | gold quality |
| pituitary gland | UBERON:0000007 | 98.49 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 98.49 | gold quality |
| hypothalamus | UBERON:0001898 | 98.45 | gold quality |
| amniotic fluid | UBERON:0000173 | 98.44 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.33 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 98.32 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 98.31 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 98.31 | gold quality |
| lower lobe of lung | UBERON:0008949 | 98.30 | gold quality |
| right frontal lobe | UBERON:0002810 | 98.29 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 98.29 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 98.23 | gold quality |
| gingiva | UBERON:0001828 | 98.20 | gold quality |
| gingival epithelium | UBERON:0001949 | 98.20 | gold quality |
| amygdala | UBERON:0001876 | 98.16 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 98.16 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 98.12 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 19.68 |
| E-HCAD-10 | yes | 16.94 |
| E-MTAB-7249 | no | 37194.32 |
| E-MTAB-6075 | no | 696.64 |
| E-MTAB-7303 | no | 438.65 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SMAD7, TP53
miRNA regulators (miRDB)
54 targeting STRAP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-652-5P | 99.91 | 67.49 | 505 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4645-3P | 99.76 | 69.33 | 993 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-549A-3P | 99.54 | 68.17 | 825 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-942-5P | 99.41 | 68.40 | 1977 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-122B-3P | 99.21 | 68.90 | 1333 |
| HSA-MIR-21-3P | 99.21 | 68.95 | 1312 |
Literature-anchored findings (GeneRIF, showing 27)
- unrip functions in the pathway of small nuclear ribonucleoproteins biogenesis (PMID:15848170)
- biochemical evidence for the existence of another, yet atypical, SMN complex component, termed unr-interacting protein (unrip) (PMID:16159890)
- STRAP acts as an intermediate signaling molecule linking between the phosphatidylinositol 3-kinase/PDK1 and the TGF-beta signaling pathways (PMID:16251192)
- Gemin8 has an essential role in the proper structural organization of the SMN complex and the involvement of the heteromeric subunit containing Gemin6, Gemin7, Gemin8, and Unrip in the recruitment of Sm proteins to the snRNP assembly pathway (PMID:17023415)
- the direct interaction of NM23-H1 and STRAP is important for the regulation of TGF-beta-dependent biological activity as well as NM23-H1 activity (PMID:17314099)
- These results indicate that upregulation of STRAP might play a role in tumor development as an early event for colorectal cancers. (PMID:17316412)
- an interplay between PPM1G and unrip determine compartment-specific phosphorylation patterns, localization, and function of the SMN complex (PMID:17984321)
- Strap regulation reflects the coordinated interplay between different DNA damage-activated protein kinases, ATM and Chk2 (Checkpoint kinase 2), where phosphorylation by each kinase provides a distinct functional consequence on the activity of Strap. (PMID:18833288)
- STRAP can act as a negative regulator of ASK1. (PMID:19880523)
- gonucleotide pulldown identified STRAP (serine/threonine kinase receptor-associated protein) as a further protein recruited to the MMP28 promoter and acting functionally with Sp1. (PMID:20144149)
- B-MYB acts as a positive regulator of STRAP (PMID:21148321)
- STRAP protein decreases ubiquitination of intracellular domain of Notch3 and may help to stabilize it. (PMID:21502811)
- both of the TPR and OB-fold domains localize to the chromatin of p53 target genes and exhibit intrinsic regulatory activity necessary for the Strap-dependent p53 response (PMID:22362889)
- Coexpression of MAWBP and MAWD inhibited epithelial mesenchymal transformation, and EMT-aided malignant cell progression was suppressed in gastric cancer. (PMID:23687415)
- Data indicate serine-threonine kinase receptor-associated protein (STRAP) as a novel regulator of the coordinated translation of collagen alpha1(I) and alpha2(I) mRNAs. (PMID:23918805)
- Strap augments the apoptotic effects of mitochondrial p53. (PMID:25168243)
- STRAP inhibits the transactivation function of Sp1 either by directly blocking its DNA binding domain or destabilizing Sp1 protein through ubiquitin-proteasome pathway in cell cycle G1 phase. (PMID:25483064)
- MAWD and MAWBP were downregulated and associated with the differentiation grade in GC tissues. (PMID:26373288)
- these results suggest that STRAP increases invasion and metastasis of colorectal cancer partly through inhibiting ubiquitin-dependent degradation of beta-catenin and promoting Wnt/beta-catenin signaling (PMID:26910283)
- Findings illuminated a novel STRAP-NOTCH1-HES1 molecular axis as a CSC regulator in colorectal cancer. (PMID:28827371)
- STRAP plays an inhibitory role in hepatocellular carcinoma via regulating PTEN expression.STRAP is down-regulated in the hepatocellular carcinoma tissues. (PMID:29283497)
- Study found that STRAP and MELK were overexpressed and highly phosphorylated in samples form colorectal adenocarcinoma patients and their expression were significantly correlated with tumor stages. (PMID:29783958)
- Strap associates with Csde1 and affects expression of select Csde1-bound transcripts (PMID:30138317)
- Results show that the increased STRAP protein levels observed in HCC provide growth advantage among others by enhancing Wnt/beta-catenin signaling. (PMID:30257989)
- SIRT7 Deacetylates STRAP to Regulate p53 Activity and Stability. (PMID:32527012)
- Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism. (PMID:34520730)
- Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK). (PMID:35272839)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | strap | ENSDARG00000007405 |
| mus_musculus | Strap | ENSMUSG00000030224 |
| rattus_norvegicus | Strap | ENSRNOG00000007134 |
| drosophila_melanogaster | wmd | FBGN0034876 |
Protein
Protein identifiers
Serine-threonine kinase receptor-associated protein — Q9Y3F4 (reviewed: Q9Y3F4)
Alternative names: MAP activator with WD repeats, UNR-interacting protein, WD-40 repeat protein PT-WD
All UniProt accessions (3): Q9Y3F4, F5H1G1, H0YH33
UniProt curated annotations — full annotation on UniProt →
Function. The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate. Binding of snRNA inside 5Sm triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. STRAP plays a role in the cellular distribution of the SMN complex. Negatively regulates TGF-beta signaling but positively regulates the PDPK1 kinase activity by enhancing its autophosphorylation and by significantly reducing the association of PDPK1 with 14-3-3 protein.
Subunit / interactions. Part of the core SMN complex that contains SMN1, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8 and STRAP/UNRIP. Part of the SMN-Sm complex that contains SMN1, GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8, STRAP/UNRIP and the Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG. Associates with the SMN complex in the cytoplasm but not in the nucleus. Interacts with GEMIN6; the interaction is direct. Interacts with GEMIN7; the interaction is direct. Interacts with CSDE1/UNR and MAWBP. Interacts with PDPK1. Interacts with TRIM48.
Subcellular location. Cytoplasm. Nucleus.
Similarity. Belongs to the WD repeat STRAP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y3F4-1 | 1 | yes |
| Q9Y3F4-2 | 2 |
RefSeq proteins (1): NP_009109* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
Pfam: PF00400
UniProt features (15 total): repeat 7, modified residue 3, sequence conflict 3, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3F4-F1 | 89.75 | 0.84 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 338, 312, 335
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-2173788 | Downregulation of TGF-beta receptor signaling |
| R-HSA-9764790 | Positive Regulation of CDH1 Gene Transcription |
| R-HSA-162582 | Signal Transduction |
| R-HSA-170834 | Signaling by TGF-beta Receptor Complex |
| R-HSA-2173789 | TGF-beta receptor signaling activates SMADs |
| R-HSA-9006936 | Signaling by TGFB family members |
MSigDB gene sets: 196 (showing top):
GOBP_DIGESTION, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX, PAL_PRMT5_TARGETS_UP, MODULE_151, GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME, MORF_UBE2I, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS
GO Biological Process (12): negative regulation of transcription by RNA polymerase II (GO:0000122), alternative mRNA splicing, via spliceosome (GO:0000380), spliceosomal snRNP assembly (GO:0000387), neuron differentiation (GO:0030182), maintenance of gastrointestinal epithelium (GO:0030277), negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512), retinoic acid catabolic process (GO:0034653), retinoic acid receptor signaling pathway (GO:0048384), mRNA splicing, via spliceosome (GO:0000398), mRNA processing (GO:0006397), RNA splicing (GO:0008380), protein-RNA complex assembly (GO:0022618)
GO Molecular Function (5): RNA binding (GO:0003723), mRNA binding (GO:0003729), signaling receptor binding (GO:0005102), U2 snRNP binding (GO:1990447), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829), SMN complex (GO:0032797), SMN-Sm protein complex (GO:0034719)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| TGF-beta receptor signaling activates SMADs | 1 |
| Regulation of CDH1 Gene Transcription | 1 |
| Signaling by TGFB family members | 1 |
| Signaling by TGF-beta Receptor Complex | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mRNA splicing, via spliceosome | 2 |
| RNA processing | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| Sm-like protein family complex | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| protein-RNA complex assembly | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| epithelial structure maintenance | 1 |
| digestive system process | 1 |
| transforming growth factor beta receptor signaling pathway | 1 |
| regulation of transforming growth factor beta receptor signaling pathway | 1 |
| negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 |
| diterpenoid catabolic process | 1 |
| fat-soluble vitamin catabolic process | 1 |
| retinoic acid metabolic process | 1 |
| monocarboxylic acid catabolic process | 1 |
| hormone-mediated signaling pathway | 1 |
| nuclear receptor-mediated signaling pathway | 1 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| mRNA metabolic process | 1 |
| ribonucleoprotein complex biogenesis | 1 |
| protein-containing complex assembly | 1 |
| protein-RNA complex organization | 1 |
| nucleic acid binding | 1 |
| RNA binding | 1 |
| protein binding | 1 |
| snRNP binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| SMN-Sm protein complex | 1 |
| SMN complex | 1 |
Protein interactions and networks
STRING
1452 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STRAP | GEMIN2 | O14893 | 998 |
| STRAP | PBLD | P30039 | 981 |
| STRAP | GEMIN7 | Q9H840 | 974 |
| STRAP | GEMIN6 | Q8WXD5 | 964 |
| STRAP | CSDE1 | O75534 | 941 |
| STRAP | SMN1 | Q16637 | 886 |
| STRAP | GEMIN5 | Q8TEQ6 | 881 |
| STRAP | DDX20 | Q9UHI6 | 879 |
| STRAP | GEMIN8 | Q9NWZ8 | 862 |
| STRAP | SMAD7 | O15105 | 847 |
| STRAP | NME1 | P15531 | 813 |
| STRAP | TBK1 | Q9UHD2 | 681 |
| STRAP | IRF3 | Q14653 | 681 |
| STRAP | LARP6 | Q9BRS8 | 618 |
| STRAP | GEMIN4 | P57678 | 609 |
IntAct
200 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMN1 | GEMIN2 | psi-mi:“MI:0914”(association) | 0.960 |
| STRAP | GEMIN6 | psi-mi:“MI:0407”(direct interaction) | 0.760 |
| GEMIN7 | STRAP | psi-mi:“MI:0407”(direct interaction) | 0.760 |
| STRAP | GEMIN7 | psi-mi:“MI:0407”(direct interaction) | 0.760 |
| CDK2AP1 | MTA2 | psi-mi:“MI:0914”(association) | 0.730 |
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| SNRPD2 | GEMIN2 | psi-mi:“MI:0914”(association) | 0.710 |
| STRAP | NME1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| NME1 | STRAP | psi-mi:“MI:0915”(physical association) | 0.670 |
| STRAP | NME1 | psi-mi:“MI:0403”(colocalization) | 0.670 |
| STRAP | NME1 | psi-mi:“MI:0407”(direct interaction) | 0.670 |
| HTT | STRAP | psi-mi:“MI:0915”(physical association) | 0.670 |
| SNRNP70 | GEMIN2 | psi-mi:“MI:0914”(association) | 0.640 |
| CFTR | HAX1 | psi-mi:“MI:0914”(association) | 0.610 |
BioGRID (415): STRAP (Affinity Capture-MS), STRAP (Affinity Capture-RNA), STRAP (Affinity Capture-RNA), STRAP (Affinity Capture-MS), STRAP (Affinity Capture-MS), SMAD3 (Phenotypic Suppression), STRAP (Phenotypic Suppression), STRAP (Affinity Capture-MS), STRAP (Affinity Capture-Western), CTPS1 (Co-fractionation), PLCG1 (Co-fractionation), UBA6 (Co-fractionation), STRAP (Affinity Capture-MS), STRAP (Affinity Capture-MS), STRAP (Affinity Capture-MS)
ESM2 similar proteins: A4QNE6, B0BNA7, B5FZ19, O43172, O74184, Q13347, Q29RH4, Q29RZ9, Q38884, Q3KPT3, Q3MHE2, Q3UGF1, Q4R571, Q53HC9, Q561Y0, Q5E959, Q5E966, Q5M7F6, Q5M8I4, Q5MNZ6, Q5NVD0, Q5PPK9, Q5R7W0, Q5XIG8, Q5XJP1, Q5ZL16, Q5ZL33, Q640T2, Q66J51, Q68F45, Q6DUZ9, Q6H8D5, Q6H8D6, Q7ZUW6, Q8BGF3, Q8K0G5, Q8NEZ3, Q8VE80, Q91VM3, Q96J01
Diamond homologs: A1CTE6, A1DMI8, A2QVV2, B0Y7H6, B8N4F5, D9N129, P16649, P56094, Q08274, Q09019, Q0CKB1, Q10437, Q2HJH6, Q2UM42, Q4WN25, Q5RF51, Q5XIG8, Q6ZMW3, Q8TBZ3, Q96DI7, Q9P4R5, Q9VBC4, Q9Y3F4, Q9Z1Z2, O22469, Q5ZL33, A0A223GEB2, A0CH87, A0DB19, A1D3F5, A5D7H2, A5DWF4, A6H603, A6NE52, A6QX61, A6RRD4, A6ZZZ8, A8XYW9, B0XAF3, B0XQ42
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SMAD7 | up-regulates | STRAP | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 180 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Metabolism of non-coding RNA | 7 | 34.7× | 1e-07 |
| snRNP Assembly | 14 | 23.1× | 4e-13 |
| SARS-CoV-2 modulates host translation machinery | 13 | 22.7× | 3e-12 |
| mRNA Splicing - Minor Pathway | 6 | 10.5× | 1e-03 |
| mRNA Splicing | 12 | 10.3× | 3e-07 |
| RNA Polymerase II Transcription Termination | 6 | 10.3× | 1e-03 |
| Processing of Capped Intron-Containing Pre-mRNA | 13 | 8.3× | 8e-07 |
| mRNA Polyadenylation | 11 | 7.5× | 2e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| spliceosomal snRNP assembly | 15 | 55.9× | 2e-20 |
| U2-type prespliceosome assembly | 6 | 24.0× | 5e-05 |
| spliceosomal complex assembly | 5 | 19.3× | 1e-03 |
| circadian rhythm | 7 | 11.0× | 9e-04 |
| mRNA splicing, via spliceosome | 15 | 8.8× | 1e-07 |
| negative regulation of translation | 7 | 8.8× | 3e-03 |
| positive regulation of protein ubiquitination | 6 | 8.2× | 8e-03 |
| protein phosphorylation | 10 | 4.4× | 9e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2300 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:15882730:T:A | L8H | 1.000 |
| 12:15882730:T:C | L8P | 1.000 |
| 12:15882735:T:C | C10R | 1.000 |
| 12:15882736:G:A | C10Y | 1.000 |
| 12:15882737:C:G | C10W | 1.000 |
| 12:15882741:G:C | G12R | 1.000 |
| 12:15882741:G:T | G12C | 1.000 |
| 12:15882742:G:A | G12D | 1.000 |
| 12:15882742:G:T | G12V | 1.000 |
| 12:15882744:C:A | H13N | 1.000 |
| 12:15882744:C:G | H13D | 1.000 |
| 12:15882744:C:T | H13Y | 1.000 |
| 12:15882745:A:G | H13R | 1.000 |
| 12:15882746:C:A | H13Q | 1.000 |
| 12:15882746:C:G | H13Q | 1.000 |
| 12:15882751:G:C | R15P | 1.000 |
| 12:15882753:C:A | P16T | 1.000 |
| 12:15882753:C:T | P16S | 1.000 |
| 12:15882754:C:A | P16H | 1.000 |
| 12:15882754:C:G | P16R | 1.000 |
| 12:15882754:C:T | P16L | 1.000 |
| 12:15882757:T:A | V17E | 1.000 |
| 12:15882766:T:G | L20W | 1.000 |
| 12:15882771:T:C | F22L | 1.000 |
| 12:15882773:C:A | F22L | 1.000 |
| 12:15882773:C:G | F22L | 1.000 |
| 12:15882774:A:C | S23R | 1.000 |
| 12:15882776:T:A | S23R | 1.000 |
| 12:15882776:T:G | S23R | 1.000 |
| 12:15882807:A:C | S34R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000018911 (12:15882158 G>A), RS1000082506 (12:15881985 A>G), RS1000121931 (12:15902824 A>G,T), RS1000125332 (12:15888169 G>A), RS1000169718 (12:15900310 T>A), RS1000305573 (12:15903281 T>A,G), RS1000543586 (12:15886121 A>T), RS1000658261 (12:15886331 C>T), RS1000732277 (12:15881244 A>G), RS1000911564 (12:15898516 T>C), RS1000917264 (12:15892520 C>G), RS1000918817 (12:15898415 C>T), RS1001095673 (12:15881021 C>A,T), RS1001105969 (12:15891953 A>C), RS1001513173 (12:15896966 A>C)
Disease associations
OMIM: gene MIM:605986 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067330 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.75 | Kd | 17.7 | nM | CHEMBL5653589 |
| 7.75 | ED50 | 17.7 | nM | CHEMBL5653589 |
| 6.64 | Kd | 231.2 | nM | CHEMBL3752910 |
| 6.64 | ED50 | 231.2 | nM | CHEMBL3752910 |
PubChem BioAssay actives
2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149517: Binding affinity to human STRAP incubated for 45 mins by Kinobead based pull down assay | kd | 0.0177 | uM |
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149517: Binding affinity to human STRAP incubated for 45 mins by Kinobead based pull down assay | kd | 0.2312 | uM |
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, affects expression, decreases expression | 4 |
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | increases expression | 1 |
| moringin | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| deoxynivalenol | increases expression | 1 |
| trichostatin A | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| 2-bromopalmitate | decreases reaction, increases abundance, increases palmitoylation | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ochratoxin A | increases expression | 1 |
| chloropicrin | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants, Occupational | affects expression | 1 |
| Benztropine | decreases expression | 1 |
| Cadmium | decreases reaction, increases abundance, increases palmitoylation | 1 |
| Cannabidiol | increases expression | 1 |
| Clozapine | decreases expression | 1 |
| Doxorubicin | affects expression | 1 |
| Enzyme Inhibitors | increases O-linked glycosylation, decreases activity | 1 |
| Ivermectin | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652559 | Binding | Binding affinity to human STRAP incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3II | Abcam HEK293T STRAP KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.